260 related articles for article (PubMed ID: 30657957)
21. Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3.
Fuentes-Fayos AC; Vázquez-Borrego MC; Jiménez-Vacas JM; Bejarano L; Pedraza-Arévalo S; L-López F; Blanco-Acevedo C; Sánchez-Sánchez R; Reyes O; Ventura S; Solivera J; Breunig JJ; Blasco MA; Gahete MD; Castaño JP; Luque RM
Brain; 2020 Dec; 143(11):3273-3293. PubMed ID: 33141183
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of SRSF3 by antisense oligonucleotides sensitizes oral squamous cell carcinoma and breast cancer cells to paclitaxel treatment.
Sun Y; Yan L; Guo J; Shao J; Jia R
Cancer Chemother Pharmacol; 2019 Nov; 84(5):1133-1143. PubMed ID: 31515668
[TBL] [Abstract][Full Text] [Related]
23. UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells.
Oka Y; Varmark H; Vitting-Seerup K; Beli P; Waage J; Hakobyan A; Mistrik M; Choudhary C; Rohde M; Bekker-Jensen S; Mailand N
EMBO Rep; 2014 Sep; 15(9):956-64. PubMed ID: 25092792
[TBL] [Abstract][Full Text] [Related]
24. Splicing factor SRSF3 promotes the progression of cervical cancer through regulating DDX5.
Che Y; Bai M; Lu K; Fu L
Mol Carcinog; 2023 Feb; 62(2):210-223. PubMed ID: 36282044
[TBL] [Abstract][Full Text] [Related]
25. Selective defects in gene expression control genome instability in yeast splicing mutants.
Tam AS; Sihota TS; Milbury KL; Zhang A; Mathew V; Stirling PC
Mol Biol Cell; 2019 Jan; 30(2):191-200. PubMed ID: 30462576
[TBL] [Abstract][Full Text] [Related]
26. Loss of splicing factor ASF/SF2 induces G2 cell cycle arrest and apoptosis, but inhibits internucleosomal DNA fragmentation.
Li X; Wang J; Manley JL
Genes Dev; 2005 Nov; 19(22):2705-14. PubMed ID: 16260492
[TBL] [Abstract][Full Text] [Related]
27. Splicing factor SRSF3 represses translation of p21
Kim J; Park RY; Kee Y; Jeong S; Ohn T
Cell Death Dis; 2022 Nov; 13(11):933. PubMed ID: 36344491
[TBL] [Abstract][Full Text] [Related]
28. SRSF3/AMOTL1 splicing axis promotes the tumorigenesis of nasopharyngeal carcinoma through regulating the nucleus translocation of YAP1.
Xu XC; Jiang JX; Zhou YQ; He S; Liu Y; Li YQ; Wei PP; Bei JX; Sun J; Luo CL
Cell Death Dis; 2023 Aug; 14(8):511. PubMed ID: 37558679
[TBL] [Abstract][Full Text] [Related]
29. The SRSF3-MBNL1-Acin1 circuit constitutes an emerging axis to lessen DNA fragmentation in colorectal cancer via an alternative splicing mechanism.
Chen YS; Liu CW; Lin YC; Tsai CY; Yang CH; Lin JC
Neoplasia; 2020 Dec; 22(12):702-713. PubMed ID: 33142236
[TBL] [Abstract][Full Text] [Related]
30. SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma.
Yang S; Jia R; Bian Z
Biochim Biophys Acta Mol Cell Res; 2018 Sep; 1865(9):1161-1172. PubMed ID: 29857020
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-1908-5p contributes to the oncogenic function of the splicing factor SRSF3.
Kim HR; Shin CH; Lee H; Choi KH; Nam DH; Ohn T; Kim HH
Oncotarget; 2017 Jan; 8(5):8342-8355. PubMed ID: 28039456
[TBL] [Abstract][Full Text] [Related]
32. CRKL regulates alternative splicing of cancer-related genes in cervical cancer samples and HeLa cell.
Song Q; Yi F; Zhang Y; Jun Li DK; Wei Y; Yu H; Zhang Y
BMC Cancer; 2019 May; 19(1):499. PubMed ID: 31133010
[TBL] [Abstract][Full Text] [Related]
33. Truncated serine/arginine-rich splicing factor 3 accelerates cell growth through up-regulating c-Jun expression.
Kano S; Nishida K; Nishiyama C; Akaike Y; Kajita K; Kurokawa K; Masuda K; Kuwano Y; Tanahashi T; Rokutan K
J Med Invest; 2013; 60(3-4):228-35. PubMed ID: 24190040
[TBL] [Abstract][Full Text] [Related]
34. CircSMARCA5 Inhibits Migration of Glioblastoma Multiforme Cells by Regulating a Molecular Axis Involving Splicing Factors SRSF1/SRSF3/PTB.
Barbagallo D; Caponnetto A; Cirnigliaro M; Brex D; Barbagallo C; D'Angeli F; Morrone A; Caltabiano R; Barbagallo GM; Ragusa M; Di Pietro C; Hansen TB; Purrello M
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415469
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of serine/arginine-rich splicing factor 3 induces G1 cell cycle arrest and apoptosis in colon cancer cells.
Kurokawa K; Akaike Y; Masuda K; Kuwano Y; Nishida K; Yamagishi N; Kajita K; Tanahashi T; Rokutan K
Oncogene; 2014 Mar; 33(11):1407-17. PubMed ID: 23503458
[TBL] [Abstract][Full Text] [Related]
36. Multiple effects of digoxin on subsets of cancer-associated genes through the alternative splicing pathway.
Lu GY; Liu ST; Huang SM; Chang YL; Lin WS
Biochimie; 2014 Nov; 106():131-9. PubMed ID: 25193633
[TBL] [Abstract][Full Text] [Related]
37. Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinoma.
Webster NJG; Kumar D; Wu P
Sci Rep; 2024 Jan; 14(1):2500. PubMed ID: 38291075
[TBL] [Abstract][Full Text] [Related]
38. SRSF3, a Splicer of the PKM Gene, Regulates Cell Growth and Maintenance of Cancer-Specific Energy Metabolism in Colon Cancer Cells.
Kuranaga Y; Sugito N; Shinohara H; Tsujino T; Taniguchi K; Komura K; Ito Y; Soga T; Akao Y
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30279379
[TBL] [Abstract][Full Text] [Related]
39. Splicing, genome stability and disease: splice like your genome depends on it!
Tam AS; Stirling PC
Curr Genet; 2019 Aug; 65(4):905-912. PubMed ID: 30953124
[TBL] [Abstract][Full Text] [Related]
40. Hepatocyte Deletion of IGF2 Prevents DNA Damage and Tumor Formation in Hepatocellular Carcinoma.
Kumar D; Das M; Oberg A; Sahoo D; Wu P; Sauceda C; Jih L; Ellies LG; Langiewicz MT; Sen S; Webster NJG
Adv Sci (Weinh); 2022 Jul; 9(21):e2105120. PubMed ID: 35615981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]